Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Immunovant Inc (NASDAQ: IMVT) closed at $15.26 in the last session, up 0.26% from day before closing price of $15.22. In other words, the price has increased by $0.26 from its previous closing price. On the day, 1.06 million shares were traded. IMVT stock price reached its highest trading level at $15.52 during the session, while it also had its lowest trading level at $15.17.
Ratios:
We take a closer look at IMVT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.32 and its Current Ratio is at 12.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 03, 2025, Jefferies started tracking the stock assigning a Hold rating and target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 23 ’25 when Stout Jay S sold 2,805 shares for $18.15 per share. The transaction valued at 50,911 led to the insider holds 204,919 shares of the business.
Geffner Michael sold 2,385 shares of IMVT for $43,288 on Jul 23 ’25. The Chief Medical Officer now owns 221,825 shares after completing the transaction at $18.15 per share. On Jul 09 ’25, another insider, Geffner Michael, who serves as the Chief Medical Officer of the company, sold 1,160 shares for $17.24 each. As a result, the insider received 19,998 and left with 224,210 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2660077312 and an Enterprise Value of 2061163008.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.45, which has changed by -0.51586294 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is -7.44%, while the 200-Day Moving Average is calculated to be -23.39%.
Shares Statistics:
According to the various share statistics, IMVT traded on average about 1.29M shares per day over the past 3-months and 1139990 shares per day over the past 10 days. A total of 171.07M shares are outstanding, with a floating share count of 70.59M. Insiders hold about 59.50% of the company’s shares, while institutions hold 55.31% stake in the company. Shares short for IMVT as of 1753920000 were 16428594 with a Short Ratio of 12.77, compared to 1751241600 on 20443952. Therefore, it implies a Short% of Shares Outstanding of 16428594 and a Short% of Float of 29.060000000000002.
Earnings Estimates
The stock of Immunovant Inc (IMVT) is currently in the spotlight, with 12.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.6 and low estimates of -$0.87.
Analysts are recommending an EPS of between -$2.33 and -$3.32 for the fiscal current year, implying an average EPS of -$2.88. EPS for the following year is -$2.96, with 9.0 analysts recommending between -$1.96 and -$3.98.
